Participation of corticotropin-releasing factor type 2 receptors in the acute, chronic and withdrawal actions of nicotine associated with feeding behavior in rats

Appetite

Volumn 53, Issue 3, 2009, Pages 354-362

  Kamdi, Sandesh P ^a   Nakhate, Kartik T ^a   Dandekar, Manoj P ^a   Kokare, Dadasaheb M ^a   Subhedar, Nishikant K ^b  

^a Department of Pharmaceutical Sciences ^*  (India)

^b INDIAN INSTITUTE OF SCIENCE EDUCATION AND RESEARCH   (India)

Author keywords

Body weight; CRF2 receptor; Food intake; Nicotine; Urocortin

Indexed keywords

ASTRESSIN; CORTICOTROPIN RELEASING FACTOR RECEPTOR 2; NICOTINE; UROCORTIN I;

ANIMAL EXPERIMENT; ANIMAL FOOD; ANIMAL MODEL; ANOREXIA; ARTICLE; BODY WEIGHT; FEEDING BEHAVIOR; FOOD INTAKE; HYPERPHAGIA; HYPOTHALAMUS PERIVENTRICULAR NUCLEUS; MALE; NONHUMAN; RAT; WEIGHT GAIN; WEIGHT REDUCTION;

ANIMALS; ANOREXIA; CORTICOTROPIN-RELEASING HORMONE; DOSE-RESPONSE RELATIONSHIP, DRUG; EATING; FEEDING BEHAVIOR; HYPERPHAGIA; INJECTIONS, INTRAPERITONEAL; KINETICS; MALE; NICOTINE; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; PEPTIDE FRAGMENTS; PEPTIDES, CYCLIC; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; SUBSTANCE WITHDRAWAL SYNDROME; UROCORTINS; WEIGHT GAIN; WEIGHT LOSS;

EID: 70449112015     PISSN: 01956663     EISSN: 10958304     Source Type: Journal    
DOI: 10.1016/j.appet.2009.07.017     Document Type: Article

References (72)

1. Albanes D., Jones D.Y., Micozzi M.S., and Mattson M.E. Associations between smoking and body weight in the US population: analysis of NHANES II. American Journal of Public Health 77 4 (1987) 439-444
2. Andersson K., Fuxe K., Eneroth P., Mascagni F., and Agnati L.F. Effects of acute intermittent exposure to cigarette smoke on catecholamine levels and turnover in various types of hypothalamic DA and NA nerve terminal systems as well as on the secretion of adenohypophyseal hormones and corticosterone. Acta Physiologica Scandianavica 124 2 (1985) 277-285
3. Arai M., Assil I.Q., and Abou-Samra A.B. Characterization of three corticotropin-releasing factor receptors in catfish: a novel third receptor is predominantly expressed in pituitary and urophysis. Endocrinology 142 1 (2001) 446-454
4. Bakshi V.P., Newman S.M., Smith-Roe S., Jochman K.A., and Kalin N.H. Stimulation of lateral septum CRF2 receptors promotes anorexia and stress-like behaviors: functional homology to CRF1 receptors in basolateral amygdala. The Journal of Neuroscience 27 39 (2007) 10568-10577
5. Bellinger L., Cepeda-Benito A., and Wellman P.J. Meal patterns in male rats during and after intermittent nicotine administration. Pharmacology, Biochemistry and Behavior 74 2 (2003) 495-504
6. Bishop C., Parker G.C., and Coscina D.V. Nicotine and its withdrawal alter feeding induced by paraventricular hypothalamic injections of neuropeptide Y in Sprague-Dawley rats. Psychopharmacology 162 3 (2002) 265-272
7. Bishop C., Parker G.C., and Coscina D.V. Systemic nicotine alters whole-body fat utilization in female rats. Physiology & Behavior 80 4 (2004) 563-567
8. Bittencourt J.C., Vaughan J., Arias C., Rissman R.A., Vale W.W., and Sawchenko P.E. Urocortin expression in rat brain: evidence against a pervasive relationship of urocortin-containing projections with targets bearing type 2 CRF receptors. The Journal of Comparative Neurology 415 3 (1999) 285-312
9. Chae Y., Yeom M., Han J.H., Park H.J., Hahm D.H., Shim I., et al. Effect of acupuncture on anxiety-like behavior during nicotine withdrawal and relevant mechanisms. Neuroscience Letters 430 2 (2008) 98-102
10. Chajek-Shaul T., Friedman G., Dabach Y., Hollander G., Bardach E., Biber A., et al. The effect of acute and chronic administration of nicotine on lipoprotein lipase activity. International Angiology 6 1 (1987) 29-36
11. Chalmers D.T., Lovenberg T.W., and De Souza E.B. Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression. The Journal of Neuroscience 15 10 (1995) 6340-6350
12. Cullen M.J., Ling N., Foster A.C., and Pelleymounter M.A. Urocortin, corticotropin releasing factor-2 receptors and energy balance. Endocrinology 142 3 (2001) 992-999
13. Dandekar M.P., Singru P.S., Kokare D.M., Lechan R.M., Thim L., Clausen J.T., et al. Importance of cocaine- and amphetamine-regulated transcript peptide in the central nucleus of amygdala in anxiogenic responses induced by ethanol withdrawal. Neuropsychopharmacology 33 5 (2008) 1127-1136
14. Dandekar M.P., Singru P.S., Kokare D.M., and Subhedar N.K. Cocaine- and amphetamine-regulated transcript peptide plays a role in the manifestation of depression: social isolation and olfactory bulbectomy models reveal unifying principles. Neuropsychopharmacology 34 5 (2009) 1288-1300
15. Frankham P., and Cabanac M. Nicotine lowers the body-weight set-point in male rats. Appetite 41 1 (2003) 1-5
16. Frankish H.M., Dryden S., Wang Q., Bing C., MacFarlane I.A., and Williams G. Nicotine administration reduces neuropeptide Y and neuropeptide Y mRNA concentrations in the rat hypothalamus: NPY may mediate nicotine's effects on energy balance. Brain Research 694 1-2 (1995) 139-146
17. George O., Ghozland S., Azar M.R., Cottone P., Zorrilla E.P., Parsons L.H., et al. CRF-CRF1 system activation mediates withdrawal-induced increases in nicotine self-administration in nicotine-dependent rats. Proceedings of the National Academy of Sciences of the United States of America 104 46 (2007) 17901-17902
18. Gosnell B.A., Morley J.E., and Levine A.S. A comparison of the effects of corticotropin releasing factor and sauvagine on food intake. Pharmacology, Biochemistry and Behavior 19 5 (1983) 771-775
19. Goyal S.N., Kokare D.M., Chopde C.T., and Subhedar N.K. Alpha-melanocyte stimulating hormone antagonizes antidepressant-like effect of neuropeptide Y in Porsolt's test in rats. Pharmacology, Biochemistry and Behavior 85 2 (2006) 369-377
20. Grunberg N.E., Bowen D.J., and Morse D.E. Effects of nicotine on body weight and food consumption in rats. Psychopharmacology 83 1 (1984) 93-98
21. Hashimoto K., Nishiyama M., Tanaka Y., Noguchi T., Asaba K., Hossein P.N., et al. Urocortins and corticotropin releasing factor type 2 receptors in the hypothalamus and the cardiovascular system. Peptides 25 10 (2004) 1711-1721
22. Heinrichs S.C., Joppa M., Lapsansky J., Jeske K., Nelson R., and De Souza E. Selective stimulatory actions of corticotropin-releasing factor ligands on correlates of energy balance. Physiology & Behavior 74 1-2 (2001) 5-13
23. Heinrichs S.C., Lapsansky J., Behan D.P., Chan R.K., Sawchenko P.E., Lorang M., et al. Corticotropin-releasing factor-binding protein ligand inhibitor blunts excessive weight gain in genetically obese Zucker rats and rats during nicotine withdrawal. Proceedings of the National Academy of Sciences of the United States of America 93 26 (1996) 15475-15480
24. Heinrichs S.C., Li D.L., and Iyengar S. Corticotropin-releasing factor (CRF) or CRF binding-protein ligand inhibitor administration suppresses food intake in mice and elevates body temperature in rats. Brain Research 900 2 (2001) 177-185
25. Hillhouse E.W., and Milton N.G. Effect of acetylcholine and 5-hydroxytryptamine on the secretion of corticotrophin-releasing factor-41 and arginine vasopressin from the rat hypothalamus in vitro. The Journal of Endocrinology 122 3 (1989) 713-718
26. Honma S. Sex difference in the circadian rhythm of corticotropin-releasing activity in the rat hypothalamus. Hokkaido Igaku Zasshi 51 1 (1976) 23-39
27. Hwang B.H., and Guntz J.M. Downregulation of corticotropin-releasing factor mRNA, but not vasopressin mRNA, in the paraventricular hypothalamic nucleus of rats following nutritional stress. Brain Research Bulletin 43 5 (1997) 509-514
28. Jensen E.X., Fusch C., Jaeger P., Peheim E., and Horber F.F. Impact of chronic cigarette smoking on body composition and fuel metabolism. The Journal of Clinical Endocrinology and Metabolism 80 7 (1995) 2181-2185
29. Kalra S.P., Dube M.G., Pu S., Xu B., Horvath T.L., and Kalra P.S. Interacting appetite-regulating pathways in the hypothalamic regulation of body weight. Endocrine Reviews 20 1 (1999) 68-100
30. Karanth S., Lyson K., and McCann S.M. Effects of cholinergic agonists and antagonists on interleukin-2-induced corticotropin-releasing hormone release from the mediobasal hypothalamus. Neuroimmunomodulation 6 3 (1999) 168-174
31. Kimura T., Maji T., and Ashida K. Periodicity of food intake and lipogenesis in rats subjected to two different feeding plans. The Journal of Nutrition 100 6 (1970) 691-697
32. Klesges R.C., Brown K., Pascale R.W., Murphy M., Williams E., and Cigrang J.A. Factors associated with participation, attrition, and outcome in a smoking cessation program at the workplace. Health Psychology 7 6 (1988) 575-589
33. Kokare D.M., Dandekar M.P., Chopde C.T., and Subhedar N. Interaction between neuropeptide Y and alpha-melanocyte stimulating hormone in amygdala regulates anxiety in rats. Brain Research 1043 1-2 (2005) 107-114
34. A receptors mediate orexin-A induced stimulation of food intake. Neuropharmacology 50 1 (2006) 16-24
35. Konturek P.C., Konturek J.W., Cześnikiewicz-Guzik M., Brzozowski T., Sito E., and Konturek S.J. Neuro-hormonal control of food intake: basic mechanisms and clinical implications. Journal of Physiology and Pharmacology 56 6 (2005) 5-25
36. Krahn D.D., Gosnell B.A., Levine A.S., and Morley J.E. Behavioral effects of corticotropin-releasing factor: localization and characterization of central effects. Brain Research 443 1-2 (1988) 63-69
37. Kramer P.R., Kramer S.F., Marr K., Guan G., Wellman P.J., and Bellinger L.L. Nicotine administration effects on feeding and cocaine-amphetamine-regulated transcript (CART) expression in the hypothalamus. Regulatory Peptides 138 2-3 (2007) 66-73
38. Levin E.D., Morgan M.M., Galvez C., and Ellison G.D. Chronic nicotine and withdrawal effects on body weight and food and water consumption in female rats. Physiology & Behavior 39 4 (1987) 441-444
39. Levine A.S., Winsky-Sommerer R., Huitron-Resendiz S., Grace M.K., and de Lecea L. Injection of neuropeptide W into paraventricular nucleus of hypothalamus increases food intake. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 288 6 (2005) R1727-R1732
40. Liposits Z., Paull W.K., Sétáló G., and Vigh S. Evidence for local corticotropin releasing factor (CRF)-immunoreactive neuronal circuits in the paraventricular nucleus of the rat hypothalamus. An electron microscopic immunohistochemical analysis. Histochemistry 83 1 (1985) 5-16
41. Liposits Z., Sievers L., and Paull W.K. Neuropeptide-Y and ACTH-immunoreactive innervation of corticotropin releasing factor (CRF) synthesizing neurons in the hypothalamus of the rat. An immunocytochemical analysis at the light and electron microscopic levels. Histochemistry 88 3-6 (1988) 227-234
42. Loughlin S.E., Islas M.I., Cheng M.Y., Lee A.G., Villegier A.S., and Leslie F.M. Nicotine modulation of stress-related peptide neurons. The Journal of Comparative Neurology 497 4 (2006) 575-588
43. Lovenberg T.W., Liaw C.W., Grigoriadis D.E., Clevenger W., Chalmers D.T., De Souza E.B., et al. Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain. Proceedings of the National Academy of Sciences of the United States of America 92 3 (1995) 836-840
44. Mano-Otagiri A., Iwasaki-Sekino A., Ohata H., Arai K., and Shibasaki T. Nicotine suppresses energy storage through activation of sympathetic outflow to brown adipose tissue via corticotropin-releasing factor type 1 receptor. Neuroscience Letters 455 1 (2009) 26-29
45. Marcinkiewcz C.A., Prado M.M., Isaac S.K., Marshall A., Rylkova D., and Bruijnzeel A.W. Corticotropin-releasing factor within the central nucleus of the amygdala and the nucleus accumbens shell mediates the negative affective state of nicotine withdrawal in rats. Neuropsychopharmacology 34 7 (2009) 1743-1752
46. Matta S.G., Foster C.A., and Sharp B.M. Nicotine stimulates the expression of cFos protein in the parvocellular paraventricular nucleus and brainstem catecholaminergic regions. Endocrinology 132 5 (1993) 2149-2156
47. Matta S.G., Fu Y., Valentine J.D., and Sharp B.M. Response of the hypothalamo-pituitary-adrenal axis to nicotine. Psychoneuroendocrinology 23 2 (1998) 103-113
48. Matta S.G., Valentine J.D., and Sharp B.M. Nicotinic activation of CRH neurons in extrahypothalamic regions of the rat brain. Endocrine 7 2 (1997) 245-253
49. McGowan B.M.C., Stanley S.A., Smith K.L., White N.E., Connolly M.M., Thompson E.L., et al. Central relaxin-3 administration causes hyperphagia in male wistar rats. Endocrinology 146 8 (2004) 3295-3300
50. A receptors in nucleus accumbens shell mediate the hyperphagia and weight gain following haloperidol treatment in rats. Life Sciences 84 5-6 (2009) 156-163
51. Mercer J.G., Lawrence C.B., and Atkinson T. Hypothalamic NPY and CRF gene expression in the food-deprived Syrian hamster. Physiology & Behavior 60 1 (1996) 121-127
52. Nakhate K.T., Dandekar M.P., Kokare D.M., and Subhedar N.K. Involvement of neuropeptide Y Y(1) receptors in the acute, chronic and withdrawal effects of nicotine on feeding and body weight in rats. European Journal of Pharmacology 609 1-3 (2009) 78-87
53. Okuda H., Shioda S., Nakai Y., Nakayama H., Okamoto M., and Nakashima T. Immunocytochemical localization of nicotinic acetylcholine receptor in rat hypothalamus. Brain Research 625 1 (1993) 145-151
54. Paxinos G., and Watson C. The rat brain in stereotaxic coordinates (1998), Academic Press, London
55. Pelleymounter M.A., Joppa M., Carmouche M., Cullen M.J., Brown B., Murphy B., et al. Role of corticotropin-releasing factor (CRF) receptors in the anorexic syndrome induced by CRF. The Journal of Pharmacology and Experimental Therapeutics 293 3 (2000) 799-806
56. Rao T.L., Kokare D.M., Sarkar S., Khisti R.T., Chopde C.T., and Subhedar N. GABAergic agents prevent alpha-melanocyte stimulating hormone induced anxiety and anorexia in rats. Pharmacology, Biochemistry and Behavior 76 3-4 (2003) 417-423
57. Sarnyai Z., Shaham Y., and Heinrichs S.C. The role of corticotropin-releasing factor in drug addiction. Pharmacological Reviews 53 2 (2001) 209-243
58. Sawchenko P.E., Imaki T., Potter E., Kovács K., Imaki J., and Vale W. The functional neuroanatomy of corticotropin-releasing factor. Ciba Foundation Symposium 172 (1993) 5-21 discussion 21-9
59. Sellini M., Baccarini S., Dimitriadis E., Sartori M.P., and Letizia C. Effect of smoking on the hypophyseo-adrenal axis. Medicina (Firenze) 9 2 (1989) 194-196
60. Semba J., Wakuta M., Maeda J., and Suhara T. Nicotine withdrawal induces subsensitivity of hypothalamic-pituitary-adrenal axis to stress in rats: implications for precipitation of depression during smoking cessation. Psychoneuroendocrinology 29 2 (2004) 215-226
61. Sharp B.M., Nicol S., Cummings S., and Seybold V. Distribution of nicotinic binding sites with respect to CRF and neurophysin immunoreactive perikarya within the rat hypothalamus. Brain Research 422 2 (1987) 361-366
62. Shor-Posner G., Azar A.P., Insinga S., and Leibowitz S.F. Deficits in the control of food intake after hypothalamic paraventricular nucleus lesions. Physiology & Behavior 35 6 (1985) 883-890
63. Spina M., Merlo-Pich E., Chan R.K., Basso A.M., Rivier J., Vale W., et al. Appetite-suppressing effects of urocortin, a CRF-related neuropeptide. Science 273 5281 (1996) 1561-1564
64. Tucci S.A., Rogers E.K., Korbonits M., and Kirkham T.C. The cannabinoid CB1 receptor antagonist SR141716 blocks the orexigenic effects of intrahypothalamic ghrelin. British Journal of Pharmacology 143 5 (2004) 520-523
65. Valentine J.D., Matta S.G., and Sharp B.M. Nicotine-induced cFos expression in the hypothalamic paraventricular nucleus is dependent on brainstem effects: correlations with cFos in catecholaminergic and noncatecholaminergic neurons in the nucleus tractus solitarius. Endocrinology 137 2 (1996) 622-630
66. Vaughan J., Donaldson C., Bittencourt J., Perrin M.H., Lewis K., Sutton S., et al. Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature 378 6554 (1995) 233-234
67. Wahlestedt C., Skagerberg G., Ekman R., Heilig M., Sundler F., and Håkanson R. Neuropeptide Y (NPY) in the area of the hypothalamic paraventricular nucleus activates the pituitary-adrenocortical axis in the rat. Brain Research 417 1 (1987) 33-38
68. Ward H., Gardiner J., Kong W.M., Murphy K., and Bloom S. Distribution of fluorescence following injection of recombinant adeno-associated virus encoding green fluorescent protein into the paraventricular nucleus. Neuroendocrinology 77 2 (2003) 100-104
69. Wingkar K.C. Alterations in feeding and sexual behaviour during reproductive cycle in female rats. Indian Journal of Physiology and Pharmacology 36 3 (1992) 174-176
70. Wolfson B., Manning R.W., Davis L.G., Arentzen R., and Baldino Jr. F. Co-localization of corticotropin releasing factor and vasopressin mRNA in neurones after adrenalectomy. Nature 315 6014 (1985) 59-61
71. Wynn P.C., Harwood J.P., Catt K.J., and Aguilera G. Corticotropin-releasing factor (CRF) induces desensitization of the rat pituitary CRF receptor-adenylate cyclase complex. Endocrinology 122 1 (1988) 351-358
72. Yu G., Chen H., Zhao W., Matta S.G., and Sharp B.M. Nicotine self-administration differentially regulates hypothalamic corticotropin-releasing factor and arginine vasopressin mRNAs and facilitates stress-induced neuronal activation. The Journal of Neuroscience 28 11 (2008) 2773-2782